LexBlog IP

JUNE 16, 2022

Sometimes the FTC will do reports on its own initiative (such as the recently announced pharmacy benefit managers (PBMs) study ), but other times, Congress will, through legislation, require the Commission to prepare a report on a specific topic, and that is often done as part of the agency appropriation process.

Reporting 52

Reporting Law Intellectual Property 52

LexBlog IP

AUGUST 17, 2022

It is not every day that the FTC sues the CEO of a publicly traded company, and it is even less often that we see a federal court opinion on the topic, so this decision warrants a deep dive. Background. But before we focus on the decision, we need to get some unusually messy procedural history tied to the AMG decision out of the way. [T]he

Litigation 52

Litigation Advertising Advertising Reporting 52

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

Branded Semglee ® : 5% off WAC of Lantus ® , with high rebates. The letter discusses the BPCIA and the Hatch-Waxman Act frameworks (for small molecule drugs) and sets forth several topics for USPTO’s consideration and further discussion: engagement between FDA and USPTO to increase efficiencies, possible misuse of the patent system (e.g.,

Litigation 52

Litigation Settlement Patent Marketing 52